RegenLab USA, which manufactures devices for the production of regenerative cell therapy, will relocate from the Brooklyn Army Terminal in New York to occupy 15,792 square feet across the sixth floor of the recently completed property in the second quarter. The company will use the space for office, research and manufacturing of medical devices and platelet-rich plasma products.
“We are pleased to welcome RegenLab to 95 Greene St. and are confident their talented team will thrive in their new state-of-the-art headquarters. Ideally located in one of the leading life science markets in the country, 95 Greene offers a range of amenities, unmatched access to talent and central location just minutes from Manhattan,” Melissa Gliatta, chief operating officer of Thor Equities, said.
Originally built as a manufacturing plant for Colgate Palmolive, 95 Greene St. is an eight-story, 350,000-square-foot property redeveloped by Thor to meet surging demand from life science companies seeking custom space in well-located markets.
The property offers abundant power resources served by multiple utility grids, 13- to 15-foot ceiling heights, secured interior loading docks, an on-site life-safety generator and flexible floor plates. Onsite underground parking is available for 125 vehicles.
Thor worked with SGA Architects to complete the comprehensive adaptive reuse project, which included extensive upgrades to mechanicals, HVAC, vertical conduits and a new rooftop generator.
JLL Senior Managing Director Dan Spero, Managing Director Blake Goodman, Senior Vice Presidents John Cahill and Bob Ryan and Executive Vice President Craig Eisenhardt serve as exclusive agents for 95 Greene St. and represented Thor Equities Group and RegenLab in the lease negotiations.
RegenLab is the latest tenant to relocate from New York City to 95 Greene St. in the past 18 months. To date, the JLL team has arranged approximately 75,000 square feet of new leases with tenants including Jersey City Medical Center and cellular agriculture company Fork & Good Inc.
“We are seeing significant activity from companies like RegenLab seeking to relocate from New York to best-in-class properties highly accessible to a skilled labor pool,” Goodman said. “95 Greene offers a powerful destination given its proximity to both New York City and New Jersey talent, with great transit access from both sides.”